tACS Improves Memory in Elders With Subjective Memory Complaints

Sponsor
University of Tehran (Other)
Overall Status
Completed
CT.gov ID
NCT05569902
Collaborator
(none)
16
1
2
10
1.6

Study Details

Study Description

Brief Summary

Subjective memory complaints (SMC), the main cognitive component of which is event memory, is a predictor of Alzheimer's disease in elderly people. The purpose of this study was to investigate the effect of transcranial alternating current stimulation (tACS) with theta frequency (6 Hz) on the medial prefrontal cortex in the improvement of episodic memory in individuals with SMC in a double blind, randomized, and sham-controlled parallel study. Sixteen participants with SMC received either active or sham theta tACS on the medial prefrontal cortex (mPFC). EEG was recorded and Rey Auditory Verbal Learning Test (RAVLT) was administered. The aim of the current study was to see if theta tACS over the mPFC can improve event memory in individuals with SMC and thus can be considered a potential therapeutic intervention for this population or not.

Condition or Disease Intervention/Treatment Phase
  • Device: active tACS
  • Device: sham tACS
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Remember NIBS? tACS Improves Memory Performance in Elders With Subjective Memory Complaints
Actual Study Start Date :
Oct 1, 2021
Actual Primary Completion Date :
Jun 1, 2022
Actual Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active tACS

Participants in this group received 20 minutes of active 6 Hz stimulation over the medial prefrontal cortex.

Device: active tACS
transcranial alternating current stimulation is a non-invasive method of entraining specific frequency bands in the brain by applying weak intensities of electric current in a desired shape and phase to the desired brain regions.

Sham Comparator: Sham tACS

Participants in this group received 20 minutes of sham stimulation over the medial prefrontal cortex.

Device: sham tACS
transcranial alternating current stimulation is a non-invasive method of entraining specific frequency bands in the brain by applying weak intensities of electric current in a desired shape and phase to the desired brain regions.

Outcome Measures

Primary Outcome Measures

  1. Change in performance [25 minutes i.e., before versus after the stimulation]

    Rey auditory-verbal learning test (RAVLT)

Secondary Outcome Measures

  1. Change in EEG power in theta frequency band [30 minutes, i.e., before versus after stimulation]

    Spectral analysis measuring power in different frequency bands

  2. Change in phase synchronization connectivity in theta frequency band [30 minutes, i.e., before versus after stimulation]

    Phase relations between neural signals realized by means of phase-locking values (PLV)

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being 50 or older,

  • Mini Mental State Examination (MMSE) grade from 27 to 30

  • Total score of 58 or more on the Everyday Memory Questionnaire (EMQ)

  • no indications of depression and anxiety measured by Geriatric Depression Scale (GDS) and State-Trait Anxiety Inventory (STAI)

  • No sign of dementia based on Diagnostic and statistical manual of mental disorder, 5th edition (DSM-V) criteria

Exclusion Criteria:
  • History of a major psychological or neurological condition

  • History of head trauma leading to unconsciousness,

  • Presence of metal in the head

  • History of seizures

  • Serious cardiovascular disease

  • Use of medications with an impact on cognitive functions

  • Recent use of alcohol or substance abuse

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Brain Mapping Lab Tehran Iran, Islamic Republic of 1439957131

Sponsors and Collaborators

  • University of Tehran

Investigators

  • Study Director: Reza Rostami, M.D., University of Tehran
  • Principal Investigator: Sahereh Varastegan, MSc, University of Tehran

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
reza kazemi, Assistant professor, University of Tehran
ClinicalTrials.gov Identifier:
NCT05569902
Other Study ID Numbers:
  • tACS
First Posted:
Oct 6, 2022
Last Update Posted:
Oct 10, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by reza kazemi, Assistant professor, University of Tehran
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2022